Alliancebernstein L.P. trimmed its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 55.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 120,561 shares of the company's stock after selling 149,131 shares during the period. Alliancebernstein L.P. owned approximately 0.13% of Acadia Healthcare worth $4,780,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also recently modified their holdings of the company. Wellington Management Group LLP boosted its stake in shares of Acadia Healthcare by 0.7% during the 4th quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company's stock worth $465,283,000 after purchasing an additional 76,490 shares during the period. Clearbridge Investments LLC boosted its position in shares of Acadia Healthcare by 19.6% during the fourth quarter. Clearbridge Investments LLC now owns 326,886 shares of the company's stock valued at $12,961,000 after buying an additional 53,547 shares during the period. WINTON GROUP Ltd bought a new position in shares of Acadia Healthcare during the fourth quarter valued at approximately $436,000. Zions Bancorporation N.A. raised its holdings in shares of Acadia Healthcare by 14.1% in the fourth quarter. Zions Bancorporation N.A. now owns 14,904 shares of the company's stock worth $591,000 after buying an additional 1,844 shares during the period. Finally, LPL Financial LLC lifted its stake in shares of Acadia Healthcare by 5.4% during the 4th quarter. LPL Financial LLC now owns 55,830 shares of the company's stock worth $2,275,000 after acquiring an additional 2,869 shares during the last quarter.
Acadia Healthcare Trading Down 6.3 %
Shares of NASDAQ:ACHC traded down $1.66 during midday trading on Tuesday, reaching $24.73. 2,929,369 shares of the company's stock were exchanged, compared to its average volume of 1,485,981. The firm's 50 day simple moving average is $32.49 and its two-hundred day simple moving average is $40.58. Acadia Healthcare Company, Inc. has a fifty-two week low of $24.72 and a fifty-two week high of $82.41. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The stock has a market cap of $2.30 billion, a price-to-earnings ratio of 8.11, a P/E/G ratio of 1.46 and a beta of 1.13.
Analysts Set New Price Targets
Several brokerages recently issued reports on ACHC. Royal Bank of Canada dropped their price objective on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. KeyCorp cut their target price on shares of Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a research report on Monday, March 3rd. Guggenheim initiated coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target for the company. Barclays downgraded shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and reduced their price objective for the stock from $43.00 to $35.00 in a research note on Friday, February 28th. Finally, Bank of America dropped their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $50.39.
Read Our Latest Research Report on ACHC
About Acadia Healthcare
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.